Flavonoids and ω3-polyunsaturated fatty acid supplementation in renal transplant recipients: new arguments from COVID-19
- PMID: 34773603
- PMCID: PMC8590443
- DOI: 10.1007/s40620-021-01194-9
Flavonoids and ω3-polyunsaturated fatty acid supplementation in renal transplant recipients: new arguments from COVID-19
Conflict of interest statement
The authors have no conflict of interest to disclose.
Comment on
-
Flavonoids are promising safe therapy against COVID-19.Phytochem Rev. 2022;21(1):291-312. doi: 10.1007/s11101-021-09759-z. Epub 2021 May 22. Phytochem Rev. 2022. PMID: 34054380 Free PMC article. Review.
References
-
- Bell S, Campbell J, McDonald J, O'Neill M, Watters C, Buck K, Cousland Z, Findlay M, Lone NI, Metcalfe W, Methven S, Peel R, Almond A, Sanu V, Spalding E, Thomson PC, Mark PB, Traynor JP, Registry SR. COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry. BMC Nephrol. 2020;21:419. doi: 10.1186/s12882-020-02061-8. - DOI - PMC - PubMed
-
- Sabbatini M, Apicella L, Cataldi M, Maresca I, Nastasi A, Vitale S, Memoli B, Postiglione L, Riccio E, Gallo R, Federico S, Guida B. Effects of a diet rich in N-3 polyunsaturated fatty acids on systemic inflammation in renal transplant recipients. J Am Coll Nutr. 2013;32:375–383. doi: 10.1080/07315724.2013.826482. - DOI - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical